Overview


According to FutureWise analysis the market for Orthobiologics Devices And Equipment in 2023 is US$ 5.3 billion, and is expected to reach US$ 10.66 billion by 2031 at a CAGR of 9.10%.

Orthobiologics is another name for regenerative cellular treatment. Growth factors are utilised to aid in tissue healing, pain relief, and the restoration of normal bone function, and Orthobiologics products contain or induce the release of growth factors. These are bodily substances that are made up of naturally occurring elements. They may help to speed up the healing process if used in higher quantities. One of three key factors that contribute in the healing process following tissue damage is matrix, which is a framework where cells reside and serves as a building block that helps to repair tissue gaps. Growth factors are another example. Tissue requires a number of proteins during the healing process, some of which act as teachers and others as subtractors. Stem cells are cells that have the ability to differentiate into a variety of different types of cells. Stem cells help in tissue restoration by supplying new cells during the healing process. Matrix, growth factors, and stem cells are all Orthobiologics, and the healing process will be impeded if one of these three is missing. Others include bone transplants, autologous blood, autologous conditioned serum, and platelet-rich plasma. Blood derived, stem cell containing products, extracellular matrix, and conditioned media are the four categories of orthobiologics. Orthobiologics goods include Platelet Gel, Bone Morphogenic Proteins, and Osteoconductive Materials. Globally, the number of people over the age of 65 increased by 33%, according to forecasts based on Population Reference Bureau data. The ageing population has increased the patient pool for a variety of orthopaedic conditions, resulting in an increase in demand for orthobiologics devices and equipment. The increasing occurrence of post-surgical difficulties in patients implanted with orthobiologics devices is one of the main restrictions in the orthobiologics devices and equipment industry. Surgical techniques including orthobiologics grafts, implants, and devices have grown more common in recent years. Postoperative complications include device failures, haemorrhage, postoperative infections, immunological responses, and rejections.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Orthobiologics Devices And Equipment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Orthobiologics Devices And Equipment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Medtronic
  • Arthrex Inc
  • DePuy Synthes (A Subsidiary of Johnson & Johnson)
  • Stryker Corporation
  • Zimmer Biomet
  • Bioventus LLC.
  • Baxter International Inc.
  • Integra Lifesciences Holding Corporation
  • Nuvasive INC.
  • Sanofi

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Demineralized Bone Matrix
  • Synthetic Bone Substitutes
  • Stem Cell Therapy
  • Plasma-Rich Protein
  • Viscosupplementation
  • Bone Morphogenetic Protein
  • Synthetic Orthobiologics

By Application

  • Osteoarthritis and Degenerative Arthritis
  • Soft-Tissue Injuries
  • Fracture Recovery
  • Maxillofacial and Dental Applications
  • Spinal Fusion
  • Trauma Repair
  • Reconstructive Surgery

By End User

  • Hospitals
  • Orthopedic Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Orthobiologics Devices And Equipment Market By Product Type, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Orthobiologics Devices And Equipment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Orthobiologics Devices And Equipment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Orthobiologics Devices And Equipment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Orthobiologics Devices And Equipment Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Demineralized Bone Matrix
        2. Synthetic Bone Substitutes
        3. Stem Cell Therapy
        4. Plasma-Rich Protein
        5. Viscosupplementation
        6. Bone Morphogenetic Protein
        7. Synthetic Orthobiologics

  • 8.   Orthobiologics Devices And Equipment Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Osteoarthritis and Degenerative Arthritis
        2. Soft-Tissue Injuries
        3. Fracture Recovery
        4. Maxillofacial and Dental Applications
        5. Spinal Fusion
        6. Trauma Repair
        7. Reconstructive Surgery

  • 9.   Orthobiologics Devices And Equipment Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Orthopedic Clinics
        3. Others

  • 10.   North America Orthobiologics Devices And Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Orthobiologics Devices And Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Orthobiologics Devices And Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Orthobiologics Devices And Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Arthrex Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. DePuy Synthes (A Subsidiary of Johnson & Johnson)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Stryker Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Zimmer Biomet
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bioventus LLC.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Baxter International Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Integra Lifesciences Holding Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Nuvasive INC.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Sanofi
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients